Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-20

Clinical Trial Update: Peri-procedural Management of Direct Oral Anticoagulants for Central VENOus Catheters in CAncer Patients With Venous Thromboembolism or Atrial Fibrillation Pilot Study [NA]

View source ↗

Summary

A pilot clinical trial evaluating peri-procedural management of direct oral anticoagulants in cancer patients undergoing central venous catheter procedures, inc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apixaban (apixaban)
  • Dabigatran (Dabigatran etexilate)
  • Edoxaban (edoxaban)
  • Rivaroxaban (rivaroxaban)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Anticoagulant-induced Bleeding, Direct Oral Anticoagulant | NA | Status: NOT_YET_RECRUITING